tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
NanoViricides receives approval to start Phase II trial of NV-387
PremiumThe FlyNanoViricides receives approval to start Phase II trial of NV-387
29d ago
NanoViricides says NV-387 shows ‘strong antiviral activity’
Premium
The Fly
NanoViricides says NV-387 shows ‘strong antiviral activity’
2M ago
NanoViricides says NV-387 shows ‘strong activity’ against Measles virus
Premium
The Fly
NanoViricides says NV-387 shows ‘strong activity’ against Measles virus
2M ago
NanoViricides discusses potential of NV-387 drug
PremiumThe FlyNanoViricides discusses potential of NV-387 drug
5M ago
NanoViricides comments on extension of MPox Public Health Emergency
Premium
The Fly
NanoViricides comments on extension of MPox Public Health Emergency
5M ago
NanoViricides measles drug development animal study imminent
Premium
The Fly
NanoViricides measles drug development animal study imminent
6M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
10M ago
NanoViricides engages clinical research organization for NV-387 trial
Premium
The Fly
NanoViricides engages clinical research organization for NV-387 trial
11M ago
NanoViricides files annual report on Form 10-K
Premium
The Fly
NanoViricides files annual report on Form 10-K
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100